AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
This article compares yields from SP 500 funds and multi-asset retirement portfolios, detailing factors that influence income streams.
25,151 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Meta’s latest move signals a serious push into cloud services. This article breaks down what Mark Zuckerberg's Meta l...
Three Dow components power the year’s rally with double-digit gains. Honeywell’s split plan and Chevron’s rising prod...
A drone strike sparks fire near the UAE's Barakah nuclear plant, prompting swift emergency action. Officials say safe...
Rare earths power the tech and defense backbone of modern economies. This guide explains how to identify your favorit...
When a CFO discloses a sizable stake sale during a volatile period, investors scramble for context. This article brea...
Bitdeer has jumped ahead of MARA in self-mining hash rate among publicly traded miners, a shift highlighted by JPMorg...
FuelCell Energy leads a hydrogen stock rebound with a 15% jump as investors chase AI data center exposure. Bloom Ener...
Thinking about SpaceX stock while it trades under $200? This guide lays out how to evaluate the opportunity, potentia...
Copper futures tumbled intraday as supply climbs and demand questions linger. The move pins attention on five NYSE-li...
A jailed crypto founder weighs in on a high-stakes regulatory bill, and senators from both parties push back. The cla...
Curious if you can own SpaceX stock before its IPO through Hyperliquid? This guide explains why that pre-IPO thrill o...